HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

14-thienyl methylene matrine

has antineoplastic activity; structure in first source

Also Known As:

YYJ18 compound

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Quinolizidine Alkaloids: 54
    - Matrines: 581
      - 14-thienyl methylene matrine: 1
- 1-Ring Heterocyclic Compounds
  - Thiophenes: 257
    - 14-thienyl methylene matrine: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiophenes: 257
    - 14-thienyl methylene matrine: 1

Experts

1.	He, Guangyao: 1 article (01/2014)
2.	Liu, Yikang: 1 article (01/2014)
3.	Qi, Chenglin: 1 article (01/2014)
4.	Tan, Songhua: 1 article (01/2014)
5.	Tang, Anzhou: 1 article (01/2014)
6.	Wang, Lisheng: 1 article (01/2014)
7.	Wang, Renjun: 1 article (01/2014)
8.	Xie, Mao: 1 article (01/2014)
9.	Ye, Yu: 1 article (01/2014)
10.	Yi, Xiang: 1 article (01/2014)

Related Diseases

1.	Nasopharyngeal Carcinoma 01/01/2014 - "14-Thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro."

Related Drugs and Biologics

1.	Matrines